MYGN logo

MYGN
Myriad Genetics, Inc.

2,126
Mkt Cap
$448.84M
Volume
1.14M
52W High
$8.59
52W Low
$3.76
PE Ratio
-1.25
MYGN Fundamentals
Price
$4.94
Prev Close
$4.80
Open
$4.78
50D MA
$4.78
Beta
1.21
Avg. Volume
997,709.24
EPS (Annual)
-$3.95
P/B
1.26
Rev/Employee
$305,370.37
$629.69
Loading...
Loading...
News
all
press releases
Myriad Genetics (MYGN) to Release Quarterly Earnings on Tuesday
Myriad Genetics (NASDAQ:MYGN) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-myriad-genetics-inc-stock...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out for
Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
News Placeholder
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) have earned an average rating of "Hold" from the eleven research firms that are covering the firm, MarketBeat reports. One analyst has...
MarketBeat·14d ago
News Placeholder
Tempus AI Expands Strategic Partnership Amid Oncology Boom
TEM expands GenoPredicta rollout and deepens oncology partnerships, leveraging AI and WGS to advance cancer diagnostics and research.
Zacks·19d ago
News Placeholder
Myriad Genetics, Inc. (NASDAQ:MYGN) Sees Significant Decline in Short Interest
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totaling 8,763,576 shares, a...
MarketBeat·19d ago
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by TD Cowen
TD Cowen raised shares of Myriad Genetics to a "hold" rating in a research note on Monday...
MarketBeat·20d ago
News Placeholder
Aberdeen Group plc Purchases 246,748 Shares of Myriad Genetics, Inc. $MYGN
Aberdeen Group plc raised its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 38.6% in the fourth quarter, according to the company in its most recent filing with the...
MarketBeat·26d ago
News Placeholder
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook?
TEM's diagnostics arm surges on oncology demand, MRD adoption and rising pricing, with 2026 growth set to stay strong as sequencing and reimbursement expand.
Zacks·1mo ago
News Placeholder
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?
Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·1mo ago
News Placeholder
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Analysts
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has been given an average recommendation of "Hold" by the twelve analysts that are currently covering the firm, MarketBeat.com reports. One...
MarketBeat·1mo ago
<
1
2
...
>

Latest MYGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.